CA02825 Ixekizumab (Taltz®)
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1M
- Sector
- HEALTH
- Published
- 30 Apr 2025
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act
1 buyer
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Eli Lilly Basingstoke
Description
Supply of ixekizumab for new patients treated in NHS Scotland
Total Quantity or Scope
Supply of Ixekizumab (Taltz®) to NHS Scotland. The Authority has awarded this framework as a single supplier framework agreement to one (1) Framework Participant.
Award Detail
| 1 | Eli Lilly (Basingstoke)
|
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Legal Justification
The medicines awarded to the individual framework agreements are protected by exclusive rights, including intellectual property rights, in
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.I.7 and section V.2.4 covers the eight (8) month contract duration. (SC Ref:797440)
Reference
- ocds-h6vhtk-0509d4
- FTS 017857-2025